Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)

Biogen (BIIB) recorded quarterly Goodwill & Intangibles of $15.5 billion in Q1 2026, down 0.81% quarter-over-quarter from $15.7 billion in Q4 2025, and down 3.23% on a YoY basis from $16.1 billion in Q1 2025.

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Biogen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $15.5 billion for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 3.23% year-over-year to $15.5 billion; the TTM figure through Mar 2026 stood at $15.5 billion (down 3.23% YoY), while the FY2025 annual figure was $15.7 billion, down 3.1% from the prior year.
  • Goodwill & Intangibles was $15.5 billion for Q1 2026 at Biogen, down from $15.7 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $16.3 billion in Q3 2024 to a low of $6.9 billion in Q3 2023.
  • Historically, Goodwill & Intangibles has averaged $12.2 billion across 5 years, with a median of $14.5 billion in 2024.
  • The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles dropped 10.87% in 2023, then surged 135.85% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $7.6 billion in 2022, then soared by 91.89% to $14.6 billion in 2023, then climbed by 10.89% to $16.2 billion in 2024, then decreased by 3.1% to $15.7 billion in 2025, then declined by 0.81% to $15.5 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $15.5 billion (Q1 2026), $15.7 billion (Q4 2025), and $15.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Biogen 28.75 Bn 24.47 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.54 Bn
Dec 31, 2025 15.67 Bn
Sep 30, 2025 15.82 Bn
Jun 30, 2025 15.96 Bn
Mar 31, 2025 16.06 Bn
Dec 31, 2024 16.17 Bn
Sep 30, 2024 16.29 Bn
Jun 30, 2024 14.46 Bn
Mar 31, 2024 14.51 Bn
Dec 31, 2023 14.58 Bn
Sep 30, 2023 6.91 Bn
Jun 30, 2023 7.53 Bn
Mar 31, 2023 7.57 Bn
Dec 31, 2022 7.60 Bn
Sep 30, 2022 7.75 Bn
Jun 30, 2022 7.82 Bn
Mar 31, 2022 7.91 Bn
Dec 31, 2021 7.98 Bn
Sep 30, 2021 8.05 Bn
Jun 30, 2021 8.15 Bn